siRNA 非病毒 递送载体 现状

· 1442 · 药学学报 Acta Pharmaceutica Sinica 2011, 46 (12): 1436 1443

as gene carriers [J]. Macromol Rapid Commun, 2010, 31: 1122 1133.

[25] Lü M, Hang W, Gao ZG, et al. Development of siRNA

delivery mediated by polyethylenimine and its derivatives [J]. Chin Pharm J (中国药学杂志), 2011, 46: 81 84.

[26] Yang H, Che O, Chen S, et al. Silence of VEGFR2 expression

mediated by PEI/siRNA complexes [J]. Acta Pharm Sin (药学学报), 2010, 45: 576 581.

[27] Unwalla H, Rossi JJ. Tat-regulated expression of RNA

interference: triggers for the treatment of HIV infection [J]. Curr HIV/AIDS Rep, 2008, 5: 40 43.

[28] Wu Y, Wang WW, Chen YT, et al. The investigation of

polymer-siRNA nanoparticle for gene therapy of gastric cancer in vitro [J]. Int J Nanomed, 2010, 5: 129 136.

[29] Malek A, Merkel O, Fink L, et al. In vivo pharmacokinetics,

tissue distribution and underlying mechanisms of various (PEI-PEG)/siRNA complexes [J]. Toxicol Appl Pharmacol, 2009, 236: 97 108.

[30] Oskuee RK, Philipp A, Dehshahri A, et al. The impact of

carboxyalkylation of branched polyethylenimine on effectiveness in small interfering RNA delivery [J]. J Gene Med, 2010, 12: 729 738.

[31] Philipp A, Zhao X, Tarcha P, et al. Hydrophobically

modi ed oligoethylenimines as highly ef cient transfection agents for siRNA delivery [J]. Bioconjug Chem, 2009, 20: 2055 2061.

[32] Kim TI, Lee M, Kim SW. A guanidinylated bioreducible

polymer with high nuclear localization ability for gene delivery systems [J]. Biomaterials, 2010, 31:1798 1804.

[33] Son S, Hwang DW, Singha K, et al. RVG peptidetethered

bioreducible polyethylenimine for gene delivery to brain [J]. J Control Release, 2011, 155: 18 25.

[34] Son S, Singha K, Kim WJ. Bioreducible BPEI-SS-PEG-

cNGR polymer as a tumor targeted nonviral gene carrier [J]. Biomaterials, 2010, 31: 6344 6354.

[35] Breunig M, Hozsa C, Lungwitz U, et al. Mechanistic

investigation of poly(ethylene imine)-based siRNA delivery: disul de bonds boost intracellular release of the cargo [J]. J Control Release, 2008, 130: 57 63.

[36] Li C, Guo T, Zhou D, et al. A novel glutathione modified

chitosan conjugate for efficient gene delivery [J]. J Control Release, 2011, 154: 177 188.

[37] Howard KA, Paludan SR, Behlke MA, et al. Chitosan/siRNA

nanoparticle-mediated TNF-α knockdown in peritoneal macro-phages for anti-inflammatory treatment in a murine arthritis model [J]. Mol Ther, 2009, 17: 162 168.

[38] Howard KA, Rahbek UL, Liu X, et al. RNA interference

in vitro and in vivo using a chitosan/siRNA nanoparticle system [J]. Mol Ther, 2006, 14: 476 484.

[39] Ghosn B, Singh A, Li M, et al. Ef cient gene silencing

in lungs and liver using imidazole-modi ed chitosan as a nanocarrier for small interfering RNA [J]. Oligonucleotides, 2010, 20: 163 172.

[40] Noh SM, Han S E, Shim G, et al. Tocopheryl oligochitosan-

based self assembling oligomersomes for siRNA delivery [J]. Biomaterials, 2011, 32: 849 857.

[41] Heidel JD, Yu Z, Liu JY, et al. Administration in non-human

primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA [J]. Proc Natl Acad Sci USA, 2007, 104: 5715 5721.

[42] Bartlett DW, Su H, Hildebrandt IJ, et al. Impact of tumor-

specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging [J]. Proc Natl Acad Sci USA, 2007, 104: 15549 15554.

[43] Bartlett DW, Davis ME. Impact of tumor-specific targeting

and dosing schedule on tumor growth inhibition after intrave-nous administration of siRNA containing nanoparticles [J]. Biotechnol Bioeng, 2008, 99: 975 985.

[44] Boe SL, Longva AS, Hovig E. Cyclodextrin containing

polymer delivery system for light-directed siRNA gene silencing [J]. Oligonucleotides, 2010, 20: 175 182.

[45] Azuma K, Nakashiro KI, Sasaki T, et al. Anti-tumor effect

of small interfering RNA targeting the androgen receptor in human androgen-independent prostate cancer cells [J]. Biochem Biophys Res Commun, 2010, 391: 1075 1079.

[46] Itaka K, Kanayama N, Nishiyama N, et al. Supramolecular

nanocarrier of siRNA from PEG-based block catiomer carrying diamineside chain with distinctive pKa directed to enhance intracellular gene silencing [J]. J Am Chem Soc, 2004, 126: 13612 13613.

[47] Kim SH, Jeong JH, Kim T, et al. VEGF siRNA delivery

system using arginine-grafted bioreducible poly(disulfide- amine) [J]. Mol Pharm, 2009, 6: 718 726.

[48] Chiu YL, Ali A, Chun CY, et al. Visualizing a correlation

between siRNA localization, cellular uptake, and RNAi in living cells [J]. Chem Biol, 2004, 11: 1165 1175.

[49] McNcmara JO, Andrechek ER, Wang Y, et al. Cell type-

specific delivery of siRNAs with aptamer-siRNA chimeras [J]. Nat Biotechnol, 2006, 24: 1005 1015.

[50] Turner JJ, Jones S, Fabani MM, et al. RNA targeting with

peptide conjugates of oligonucleotides, siRNA and PNA [J]. Blood Cells Mol Dis, 2007, 38: 1 7.

[51] Md RA, Xin M, Michael F, et al. Multivalent cyclic

RGDconjugates for targeted delivery of small interfering RNA